The prevalence of sensitization to dogs and cats varies by country, exposure time and predisposition to atopy. It is estimated that 26% of European adults coming to the clinic for suspected allergy to inhalant allergens are sensitized to cats and 27% to dogs. This document is intended to be a useful tool for clinicians involved in the management of people with dog or cat allergy. It was prepared from a consensus process based on the RAND/UCLA method. Following a literature review, it proposes various recommendations concerning the diagnosis and treatment of these patients, grounded in evidence and clinical experience. The diagnosis of dog and cat allergy is based on a medical history and physical examination that are consistent with each other and is confirmed with positive results on specific IgE skin tests. Sometimes, especially in polysensitized patients, molecular diagnosis is strongly recommended. Although the most advisable measure would be to avoid the animal, this is often impossible and associated with a major emotional impact. Furthermore, indirect exposure to allergens occurs in environments in which animals are not present. Immunotherapy is emerging as a potential solution to this problem, although further supporting studies are needed.
States, in a population over the age of 6 years, 12.1% were sensitized to cats and 11.8% to dogs. 6 It has also been estimated that around 6% of the Spanish population is sensitized to animals 7 with
figures increasing up to 30% in allergic patients. Animals are therefore the third leading cause of allergic asthma, after mites and pollens. 8 In addition to pet owners and their family members, professionals involved in animal care and research are a clearly affected group, representing up to a third of sensitized patients, with 30% of missing working days and 10% of them developing professional asthma. 7 As dog and cat allergy represents a significant health problem with unresolved questions about clinical management, diagnosis, treatment and prevention, the aim of this document was elaborating recommendations in relation to these matters, based on published evidence when available, or, otherwise, in expert clinical opinion.
| GATHERING OF EVIDE NCE AND PREPARATION OF RECOMME NDATIONS
In a previous consensus meeting, a panel of 14 allergy specialists agreed upon the main issues that should be addressed by the panel.
Then, a systematic nonexhaustive literature review was performed to extract the scientific evidence available that could provide answers to the previously agreed questions on the management of patients with dog and cat allergy. The literature search process was performed using specific keywords for each question formulated. Patient/intervention/control/outcome (PICO) methodology was used whenever applicable. Filters used were as follows: English or Spanish language, and last 5 years. The types of publications that were prioritized were clinical practice guidelines, systematic reviews, and consensus documents. The search was performed in PubMed using keywords for each question formulated on diagnosis and treatment ( Figure 1 ) (Key words are shown in Table S1 ).
Following the literature review, a consensus process based on the RAND/UCLA method was used, with the participation of the entire panel for the preparation of final recommendations ( Figure 2 ).
The specialists evaluated the evidence available and drafted recommendations and conclusions for each question, categorizing the level of evidence (LE) and degree of recommendation (DR) according to the 2011 Centre for Evidence-Based Medicine (Oxford) system. 9 Consensus was considered when a percentage of agreement ≥80%
was achieved, whereas a percentage of agreement below this threshold was established as a disagreement. Finally, a total of 27 recommendations were approved ( ; their sensitization frequencies are variable in different geographic regions. [11] [12] [13] Although there may be differences between breeds, all dogs produce allergenic proteins found in the epithelium, dander, lingual glands, prostate and parotid glands. 11 Can f 5, also known as prostatic kallikrein, is present in significant quantities only in non-neutered males. 14 
Major cat allergens are Fel d 1 and Fel d 4, although the clinical
significance of sensitization to Fel d 4 is unknown. 15 All cats produce quantities of allergens high enough to be considered clinically significant. The sources of allergens are salivary, sebaceous and perianal glands 14 (Table 1) . Fel d 1 is associated with hormone production and acts as an uteroglobin. It is found mainly in saliva, but also in sebaceous glands of the skin and in the urine of male cats. Airborne particles that carry Fel d 1 may be < 5 lm in diameter. This renders it more likely to be able to reach small bronchioles and induce asthma.
It is common for many patients to be simultaneously sensitized to both animals. 15 These patients show a higher risk of becoming sensitized to other allergens. 16 In fact, 75% of individuals sensitized to a pet are 14 times more likely to be sensitized to other animals. 16 The homology and/or structural similarity between different dog and cat allergens (such as albumins and lipocalins) explain the cross-reactivity between them and with other mammals. They also partly explain the presence of simultaneous sensitization to dogs, cats and
other mammals, 17 regardless of whether there is direct exposure to dogs, cats or both, or no direct exposure to either of them. There may be a significant cross-reactivity between dogs and cats, depending on the allergen(s) to which the patient is sensitized. It is recommended that molecular diagnosis be used to evaluate cross-reactivity [Recommendation 1, Table 2 ].
Regarding the most significant cross-reactivity patterns between cats/dogs and other mammals:
• Some lipocalins have amino acid sequences with up to 60% identity, which explains the cross-reactivity between them, for example, Can f 6 (dog), Equ c 1 (horse), Fel d 4 (cat), Ory c 4 (rabbit), Mus m 1 (mouse), Rat n 1 (rat).
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• Serum-specific Immunoglobulin E (sIgE) to Fel d 1 is present in 95% of patients who are allergic to cats and is also present in other feline families such as tigers, jaguars, pumas and lions. 6 • sIgE to Can f 6 is present in 38% of patients sensitized to dogs;
however, it appears in 60% of patients sensitized to both cats and dogs, which could be related to its identity with Fel d 4.
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• Structures of Can f 2 and Equ c 1 are quite similar; however, they do not show cross-reactivity.
• The amino acid sequences of Can f 6 and Equ c 1 have 57% identity.
• In the case of Can f 1, cross-reactivity with the human tear lipocalin has been reported.
10
• Can f 5 shows a certain homology with prostate-specific antigen (PSA), belonging to the kallikrein family. 6 Therefore, it has been speculated that prior sensitization to Can f 5 from dogs could be associated with a greater propensity for developing allergic reactions to human seminal fluid. Skin prick testing with standardized extracts, along with a targeted medical history and physical examination, should be used to ruling out discarding or confirming a suspected IgE-mediated allergy to animals.
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F I G U R E 1 Systematic non-exhaustive literature review
Skin prick tests extracts are mostly prepared by extracting allergens from several natural sources (like hair, dander, saliva, urine and/or epithelium) and contain a variety of allergenic and nonallergenic proteins. 22 Allergen extract standardization has been recommended to increase comparability and consistency between products from different manufacturers. 22 Nevertheless, in the case of dog allergy, for example, Curin et al 23 studied different commercial dog SPT extracts, founding a 20-fold variation regarding the total protein content. In addition, the concentration of Can f 1 and of Can f 2 varied considerably between the extracts, which was undetectable by immunoblotting in some extracts. The authors also observed great variability in the contents of Can f 3, albumin. Altogether, this variability between extracts should be taken into account in the evaluation of patients.
These tests are inexpensive, simple and quick to perform and should be used as an initial test. The performance of skin prick tests depends on methodological factors and factors related to the quality of the allergenic extract used [Recommendations 2 and 3, Table 2 ].
Serum-specific IgE against extract is considered to be a marker of sensitization, but it is not reliable enough to predict whether the patient is allergic or just sensitized. It should be particularly used when patient's symptoms and skin test results are contradictory, especially before recommending allergen-specific immunotherapy (AIT) 24 [Recommendation 4, Table 2 ]. In the case of cats, the determination of sIgE is a highly sensitive test, but there is a likelihood of false positives; therefore, it is less accurate than skin prick tests. 25 Molecular diagnosis refers to the diagnostic use of purified or recombinant allergens. 26, 27 It has clear advantages over the use of a complete extract, especially in polysensitized individuals, given its usefulness for distinguishing between sensitizations specific to singular species and sensitizations due to cross-reactivity. 27 It therefore aids in establishing recommendations for avoidance and assessing the choice and composition of immunotherapy. It might also be useful for predicting clinical symptoms and their severity 28 ( 31, 32 By contrast, when the exposure occurs after the first year of age, the risk of sensitization and development of an allergic disease seem to be increased. 33, 34 However, further studies are needed to confirm this finding.
These observations could be specific for cat and dog and could not occur with other mammals such as rodents. In this case, it has been described that the exposure could even increase the risk of developing nonatopic asthma. 
| Course of sensitization to dogs and cats throughout life
There is not enough available evidence to predict whether sensitization to dogs or cats will be associated or not to clinical allergy. However, sensitization to Can f 1 or Fel d 1 and polysensitization to cat and dog allergens during childhood have been associated to the development of subsequent allergy to dogs and cats. 35 Some studies have confirmed a decrease in sIgE levels after removing the source of exposure, but without significant association with clinical manifestations. 36 In addition, and although studies confirming this observations are pending, it has been described that some patients develop a lower clinical response when they are continuously exposed to significant allergen levels. 7 Thus, in patients allergic to cats, it has been From studies reviewed, 10, 14, 28, 37, 38 it could be concluded that sensitization to certain allergens seems to be associated with severity and persistence of clinical symptoms and that sensitization to more than 1 allergen or sensitization to albumins seems to be associated with more severe respiratory symptoms. It is unclear whether sensitization to dogs or cats is a risk factor for sensitization to other aeroallergens. Regarding other mammals, there seems to be an increased risk of sensitization to horses and mice in patients previously sensitized to cats/dogs, which could be related to cross-reactivity of lipocalins or albumins. 27 Therefore, in such cases it would be preferable to avoid any exposure to other mammals, although it is unknown whether cross-reactivity necessarily leads to the development of clinical symptoms [Recommendation 12, Table 2 ]. In addition, it has been described that mite-allergic patients could have a higher risk of developing sensitization to dogs if they own or have previously owned a dog. 33 
| Main food allergy syndromes in patients sensitized to dogs or cats
The existence of potential cross-reactivities in patients sensitized to dogs and cats may trigger food allergy syndromes that are difficult to manage and diagnose. In patients who are allergic to cats, the main food allergy syndrome is pork-cat syndrome, secondary to the cross-reactivity of Fel d 2 with other albumins from mammals, leading to anaphylactic reactions after consuming pork, especially raw or undercooked. 39 Other syndrome is "delayed anaphylaxis due to IgE to galactose-alpha-1,3-galactose (alpha-gal | 1211
is well-described evoking allergic symptoms after tick bites, 41 cetuximab infusion 42 and in mammalian red meat delayed allergic symptoms. 43 
| Influence of dog and cat allergy on atopic dermatitis
Due to the lack of uniformity (exposure time, duration and dose, type of pet, family history of allergy, etc.) of studies that have evaluated the role of dog and cat exposure in the development of atopic dermatitis, no definitive conclusions can be drawn. Some guidelines recommend avoiding or limiting contact with dogs and cats in patients with atopic dermatitis, depending on the severity of the signs and symptoms and the psychological stress that getting rid of the pet may cause. 44 Nevertheless, according to a recent meta-analysis, exposure to dogs from birth may decrease the risk of suffering from atopic dermatitis by 25%. 45 Regarding cats, neither a protective effect nor an increase of atopic dermatitis has been found in exposed children, except in those at high risk of developing atopic dermatitis. Concerning remission of atopic dermatitis in children, no protective effect of exposure to dogs or cats has been demonstrated. [45] [46] [47] [48] [49] [50] [51] [52] [53] As family members share microbiota with each other and with their dogs, living with a dog, although not with a cat, would alter the child's intestinal microbiota. 6, 54 Concerning exposure to cat or dog and the development or remission of atopic dermatitis, the expert panel did not achieve to a consensus on a specific recommendation.
| Quality of life in dog and cat allergy
Although no specific studies evaluating the repercussions of allergy to animals for quality of life have been found, exposure to mammals represents a significant cause of occupational allergy. 55, 56 The expert panel believes that dog or cat allergy could have a negative impact on quality of life and that it is an important aspect to be considered. 2, 7, 8 As no specific studies have been found on the impact on the quality of life of patients who are allergic to dogs and cats, recommendations are
inferences from the quality of life of patients who suffer from allergic respiratory disease [Recommendations 13 and 14, 59 applying topical lotions to the animal's fur 7 and combining several of these measures. 14 Although removing the animal from the home is the most commonly recommended measure, it may be so difficult for patients to agree to this that measures focused on decreasing exposure to allergens while keeping the pet at home, although less effective, can be more practical. The alternative described measures should preferably be applied in combination and sustained over time, although they do not ensure a current clinical benefit or a clinical benefit in disease progression [Recommendations 15-20, In women allergic to dog that refer reactions following contact with human seminal fluid, it would be advisable to determine IgE against Can f 5. What is the usefulness of specific exposure tests?
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It is recommended that specific exposure tests be performed:
• to assess the clinical significance of sensitisation to an allergen, • whenever there are discrepancies between the medical history and diagnostic skin or serum tests, • in the aetiological study of allergic respiratory diseases of occupational origin, in medical/legal situations, • in the assessment of drug efficacy • they can also be considered in the follow-up and monitoring of clinical response to allergen-specific IT.
5/D 100% (14)
Ref.
: Based on expert opinion 11 Bronchial provocation may be used to confirm or rule out the involvement of an allergen in asthmatic patients, to make an aetiological diagnosis and for research or medical/legal purposes. Very few publications have dealt in particular with specific exposure tests in allergy to epithelia. 18 Up to the point of removing the animal from the home, or if the patient does not want to remove it, it is advisable to combine multiple measures to decrease the patient's exposure, since individual measures do not seem to be useful.
: Based on 14 
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It is recommended that a combination of some of the following measures, which have demonstrated some usefulness, be used:
It is recommended that dogs and cats be washed regularly, at least twice a week, since this measure has demonstrated a reduction in the quantity of Fel d 1 from cats and Can f 1 from dogs. 57, 59, 63 4/C It can be recommended that the pet be kept out of the bedroom, since this seems to decrease allergen levels.
14,60,61
5/D
Whenever possible, the use of air purifiers with HEPA filters may be an effective measure for decreasing exposure to animal epithelia. 62, 63 5/D Regular, sustained use of high-efficiency vacuum cleaners in the homes of patients who are allergic to epithelia may be recommended 14 
The use of certain covers and cases for mattresses and pillows, especially those with a mean pore size equal to or less than 6 lm, may be beneficial for patients who are allergic to epithelia.
14,63
It is recommended that pillows and other items that may act as a reservoir be removed. 14 
In certain cases it may be recommended that chemical products (sodium hypochlorite, tannic acid) be used for washing pillows and other reservoirs. 14 
The use of night-time temperature-controlled laminar airflow may decrease allergen exposure in patients who are allergic to epithelia, since it displaces aeroallergens from the breathing area. 59 
2/B
Application of topical lotions that encapsulate the allergens on the fur of the animal that lives with patients who are allergic to epithelia may be recommended. reported to be distributed throughout the community, including schools and homes in which there are no cats. 6 Pet allergens are passively transferred from homes with pets to homes without pets and to public spaces, especially in populations in which pets are more common. 61 The extent of indirect contact is significant, as the prevalence of allergy to cats in patients who have never had a cat in their home may be as high as 34%. 65 This would require allergic patients to avoid indirect exposures using some specific measures, which is nearly impossible. 66 Houses in which there is a dog or cat have very high concentrations of allergens, even if the animal is not present at that time, and so patients can develop symptoms even in the absence of the animal. 7 It may be said that concentrations of 1-8 lg/g powder of Can f 1 and Feld 1 of 2-20 nanograms per cubic metre in the air seem to be associated with a higher risk of developing sensitization to dogs and cats as well as causing symptoms in allergic individuals. 7 Long-term exposure to cat allergens at relatively low doses may lead to adverse effects on respiratory health in atopic individuals, even without causing perceptible symptoms 67 [Recommendations 21-23, Table 2 ].
So-called "hypoallergenic" animals respond to the desire of having a cat or dog in patients sensitized to these animals. 57 Most "hy- 14 There is no scientific evidence to support labelling certain breeds of cats or dogs as hypoallergenic, as no significant differences have been found between environmental levels of allergens from nonhypoallergenic dogs vs so-called hypoallergenic dogs. 14, 57, 68 Therefore, the availability of a genuinely allergen-free dog for allergic individuals who would like to have a dog is questionable.
T A B L E 2 (Continued)
No. Recommendation a LE/DR % A (N)
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Although it is difficult to avoid indirect exposure to animal epithelia, a series of recommendations to attempt to minimise this exposure could be established:
• To reduce the dispersion of animal epithelia allergens, people could change their clothes when they travel from places with a high allergen concentration to places with a low allergen concentration.
• If people who live with an allergic patient work with or have been in contact with animals, they should change their clothes and shower before returning home.
• Family members and friends who have animals should refrain from bringing them to the home of the patient who is allergic to epithelia.
• In the case of schools, it would be advisable for students who live with pets to wear clothes that have not come into contact with these pets, and it could be recommended that the presence of animals in classes be avoided.
5/D
100% (14) Ref.
: Based on expert opinion 23 For the recommendations above to be effective, they should be followed by most of the population, and they should be strictly followed by those who live with people allergic to the epithelia of these animals. In the case of dogs, there are not enough studies to support this recommendation.
5/D 100% (14)
: Based on expert opinion
Are so-called "hypoallergenic" animals really "hypoallergenic"?
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A "hypoallergenic" pet should not be recommended to patients who are allergic to dogs or cats. 5/D 100% (14) Ref.
: Based on 14,57,68 25 Although there are animals genetically modified not to produce a major allergen (as is the case of Fel d 1), when individual sensitisation is to other clinically significant allergens, this type of animal is not useful for allergen avoidance.
5/D 100% (14)
Ref.: Based on 14 In which cases should allergen-specific IT be recommended?
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IT with cat epithelium would be indicated in patients with allergic respiratory disease under circumstances in which there is exposure, assessing the viability and efficacy of environmental control measures, drug therapy and patient preferences.
5/D 100% (14)
: Based on 107 
27
IT with dog epithelium could be recommended in certain patients under strict follow-up by their prescribing physician and using standardised extracts with the main allergens quantified, assessing the viability and efficacy of environmental control measures, drug therapy and patient preferences. 
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Patients should not be advised on the safety of acquiring a "hypoallergenic" dog or cat 14, 57, 68 [Recommendations 24 and 25, Table 2 ].
| Immunotherapy in dog and cat allergy
The literature on cases in which allergen-specific IT (AIT) against aeroallergens should be prescribed is extensive, and multiple international consensuses have been reached. Such studies particularly review IT with pollens and/or mites. In the case of AIT, there are few studies, and most of them performed with cat extracts. In this regard, the expert panel for this document has established the recommendations shown in Table 2 [Recommendations 26-27, Table 2 ].
Dog allergy
Available studies on subcutaneous immunotherapy (SCIT) with dog are limited and mixed. There are only 3 double-blind, placebo-controlled, randomized studies. SCIT with a complete dog extract has demonstrated a reduction in the size of skin tests and an increase in serum IgG and IgG4 in adults and children with rhinoconjunctivitis and asthma, but not a significant clinical efficacy. [70] [71] [72] This could be due to the quality of extracts and/or to confounding factors such as sensitization to other aeroallergens. 70, 72, 73 Regarding the dose, a study conducted in 2006 concluded that a dose containing 15.0 lg Can f 1 per 0.5 mL maintenance dose produced the most consistent response 72 (Table 4) .
Cat allergy
SCIT with cat extracts has demonstrated a statistically significant improvement in specific conjunctival, nasal and bronchial provocation with cat in adults with rhinoconjunctivitis and asthma after 12 months of treatment, [73] [74] [75] as well as a significant, dose-dependent increase in total IgG and IgG4, and a reduction in the size of the skin tests. 73, 76, 77 Regarding clinical improvement, in two placebo-controlled, randomized clinical trials, SCIT with cat extracts induced significant clinical improvement in adults with rhinoconjunctivitis and asthma after 12 months of treatment. 74, 75 Even so, more clinical trials should be conducted to confirm this improvement. Only two studies have evaluated the effect of SCIT with cat extracts in children, finding a significant improvement in specific bronchial provocation with cat and in skin test reactivity, as well as an increase in specific IgG and IgG4. 73, 78 Therefore, more studies should be conducted in paediatric popula- • High levels of specific IgE against cats, dogs and horses.
• Polysensitisation to all three animals (cats, dogs and horses).
• Sensitisation to Can f 2; 1 study found that no patients with controlled asthma were sensitised to this allergen. No patients monosensitised to this allergen were found.
• Sensitisation to Can f 5. Not significant, but a trend towards association with more severe asthma has been found.
• Polysensitisation to 3 or more lipocalins. Sensitisation to any lipocalin did not confer severity, but combined sensitisation to 3 or more lipocalins did.
(B) Described associations of allergens to asthma, rhinitis and other respiratory symptoms
• Can f 1 with persistent rhinitis.
• Can f 2 with a diagnosis of asthma.
• Can f 3 with moderate/severe rhinitis and a diagnosis of asthma.
• Can f 5 with moderate/severe persistent rhinitis.
• Fel d 2 with moderate/severe rhinitis and a diagnosis of asthma.
• Fel d 4 with a diagnosis of asthma.
• Sensitisation to 2 or more allergens was associated with more severe respiratory symptoms.
• Sensitisation to albumins was associated with more severe respiratory symptoms.
• In the case of dogs and horses, sensitisation to more than 1 allergen was associated with more severe rhinitis and asthma. Open-label study comparing skin tests, specific IgE, IgG4 and specific bronchial provocation in a group of asthmatic children who maintained their symptomatic medication and received SCIT for 9 mo, vs a control group of asthmatic children who received symptomatic medication only.
The authors found lower reactivity in the skin test and better tolerance in bronchial provocation in the active group, in both cases with a significant difference vs the control group. Second placebo-controlled, doubleblind clinical trial enrolling 22 asthmatic adult and child patients with allergy to animals (7 allergic to dogs) and 17 control patients. The parameters to be evaluated were as follows: changes in symptom score, bronchial provocation with allergen, bronchial provocation with histamine, conjunctival provocation, skin tests, IgE, IgG and IgG4.
The authors concluded that there were no clear efficacy data supporting the use of IT with dog extract:
• After 12 mo of treatment: In patients with allergy to dogs only, a significant reduction was seen in the skin test, and a significant increase in IgG and IgG4, but no significant improvement was found in symptom score, conjunctival provocation or specific bronchial provocation.
71,73
• After 1 y of treatment, the trial was unblinded, and a total of 11 patients who were allergic to dogs completed 2 y of treatment. After 2 y and after 3 y of treatment, no change or significant improvement was seen with respect to the measurements made after 1 y of treatment. 112, 113 Long-term follow-up of these patients 79 : 5 y after completion of IT with dog extract, 3 of 4 patients reported sustained clinical improvement, and 5 of 6 patients who underwent specific bronchial provocation experienced worsening compared to the time of completion of IT.
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Smith DM and Coop CA 2016 11 Systematic review of studies conducted to date on IT with dog epithelium These studies observed a reduction in symptoms and better tolerance of exposure to the animal in the patients treated. However, the improvement seen was based on subjective symptoms only, as there was no control group. The authors concluded that no clearly reproducible scientific evidence has been demonstrated to confirm its efficacy in improving the symptoms of rhinitis and asthma. It seems that this lack of efficacy could be due to the quality of the extracts and the variability of the profiles of sensitization of patients allergic to dogs. This document is intended to be a tool to aid in decision-making by professionals who care for people with dog or cat allergy when 
